Nuzenio

Tradingview Hcat

Tradingview Hcat entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - TradingViewTradingView · Fri, 07 Aug 2026 21:52:00 GMT Why Health Catalyst (HCAT) Shares Are Trading Lower Today - TradingViewTradingView · Fri, 07 Aug 2026 16:30:51 GMT HCAT: Q2 2026 beat guidance, divestiture enabled debt repayment, and 2026 outlook reflects transformation - TradingViewTradingView · Thu, 06 Aug 2026 22:15:20 GMT Health Catalyst, Inc. 2026: Revenue $70.49M, EPS ($0.55) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:22:06 GMT HCAT: Q2 2026 revenue fell 13% YoY; Vitalware sale enabled debt repayment but future margins face headwinds - TradingViewTradingView · Thu, 06 Aug 2026 20:59:35 GMT HCAT: Q2 2026 revenue fell 13% but adjusted EBITDA grew 6%, with full-year revenue guided at $246M–$249M - TradingViewTradingView · Thu, 06 Aug 2026 20:14:12 GMT HCAT Q2'26 Earnings: EPS estimate is 0.03 USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:48 GMT Health Catalyst (HCAT) Q2 Earnings Report Preview: What To Look For - TradingViewTradingView · Wed, 05 Aug 2026 03:35:00 GMT

Timeline

Fri, 07 Aug 2026 21:52:00 GMTHCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - TradingView

Fri, 07 Aug 2026 16:30:51 GMTWhy Health Catalyst (HCAT) Shares Are Trading Lower Today - TradingView

Thu, 06 Aug 2026 22:15:20 GMTHCAT: Q2 2026 beat guidance, divestiture enabled debt repayment, and 2026 outlook reflects transformation - TradingView

Thu, 06 Aug 2026 21:22:06 GMTHealth Catalyst, Inc. 2026: Revenue $70.49M, EPS ($0.55) — 10-Q Summary - TradingView

Thu, 06 Aug 2026 20:59:35 GMTHCAT: Q2 2026 revenue fell 13% YoY; Vitalware sale enabled debt repayment but future margins face headwinds - TradingView

Thu, 06 Aug 2026 20:14:12 GMTHCAT: Q2 2026 revenue fell 13% but adjusted EBITDA grew 6%, with full-year revenue guided at $246M–$249M - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

HCAT9 live mentions EPS4 live mentions TradingView TradingView3 live mentions Deep Dive2 live mentions Vitalware Divestiture Reshapes2 live mentions Strategy Amid Revenue2 live mentions Shares Are Trading2 live mentions TradingView2 live mentions Health Catalyst2 live mentions Inc2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Hcat.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.